A detailed history of First Horizon Advisors, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 5,385 shares of MNKD stock, worth $33,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,385
Previous 5,385 -0.0%
Holding current value
$33,763
Previous $28,000 17.86%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

SELL
$3.91 - $5.45 $21,896 - $30,520
-5,600 Reduced 50.98%
5,385 $22,000
Q2 2023

Aug 03, 2023

BUY
$3.72 - $4.79 $20,832 - $26,824
5,600 Added 103.99%
10,985 $44,000
Q3 2018

Nov 05, 2018

BUY
$1.01 - $2.19 $5,438 - $11,793
5,385 New
5,385 $0
Q3 2018

Nov 05, 2018

SELL
$1.01 - $2.19 $5,438 - $11,793
-5,385 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$1.59 - $2.38 $8,562 - $12,816
5,385 New
5,385 $0

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.61B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.